Cancer Family

Respiratory System Neoplasm

Non-malignant2,725 active trials51 approved drugs619 evidence items

NCIt: C3355
MeSH: D012142

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (473)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 51–75 of 473 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Erratum: [Corrigendum] MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A.
Lumin Wang, Jiayi Yao, Hongfei Sun et al. · Oncol Lett · Oct 1, 2026 · PMID 42644023 · candidate dictionary pubmed
Flavokawain A inhibits high glucose-induced malignant progression of lung cancer cells by suppressing PRMT5-mediated PTEN neddylation and nuclear translocation.
Lei Zheng, Juan Li, Chao Song et al. · Oncol Lett · Oct 1, 2026 · PMID 42639435 · candidate dictionary pubmed
Combination of lonidamine with devimistat induces synergistic antitumor effects in lung cancer via multifaceted disruption of cellular energy metabolism.
Xinhe Bai, Yongfeng Yang, Yuling Luo et al. · Oncol Rep · Oct 1, 2026 · PMID 42627059 · candidate dictionary pubmed
Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.
Zhuo Chen, Meng-Lei Wang, Zhuo-Wen Zhang et al. · Transl Oncol · Oct 1, 2026 · PMID 42623870 · candidate dictionary pubmed
In silico and in vitro evaluation of synergistic anticancer effects of erucin and kaempferol from Eruca sativa against human A549 non-small cell lung cancer cells (NSCLC).
Akshay Kumar, Nakul Bhardwaj, Rahul Sharma et al. · Cytotechnology · Oct 1, 2026 · PMID 42621169 · candidate dictionary pubmed
LAPTM4B promotes gefitinib resistance and tumor stemness in non-small cell lung cancer by stabilizing RPS3 through inhibiting its ubiquitination.
Yu Jiang, Wen-Jing Xie, Rong-Wei Chen et al. · Biochim Biophys Acta Mol Cell Res · Oct 1, 2026 · PMID 42612828 ·

candidate

dictionary

pubmed

Chelerythrine and chelidonine synergistically target the adenosine pathway to improve anti-PD-L1 immunotherapy efficacy in lung cancer.

Jinglin Zhu, Ruifei Huang, Chao Huang et al. · Phytomedicine · Oct 1, 2026 · PMID 42607553 · candidate dictionary pubmed

Anticancer effects of an XPO1 inhibitor (selinexor) with sotorasib following omeprazole preconditioning in KRAS G12C-mutant non-small cell lung cancer cells in vitro and in a mouse tumor xenograft.

Jèssica González, Xueting Cai, Wenjing Diao et al. · Neoplasia · Oct 1, 2026 · PMID 42607542 · candidate dictionary pubmed

Corrigendum to "Oleandrin-mediated suppression of MELK induces apoptosis, autophagy, and ferroptosis in human non-small cell lung cancer cells" [Phytomedicine. 2025 Nov;147:157173].

Ejlal A Omer, Min Zhou, Wynand Roos et al. · Phytomedicine · Oct 1, 2026 · PMID 42603768 · candidate dictionary pubmed

Erratum to 'Comparative efficacy of osimertinib with and without radiation therapy in EGFR-mutated nonsmall cell lung cancer with brain metastases' [Seminars in Oncology 53/1 (2026) 152436].

Rafi Aibani, Jennifer Collins, Amir-Kabirian Borna et al. · Semin Oncol · Oct 1, 2026 · PMID 42586817 · candidate dictionary pubmed

Tumor microenvironment-mediated resistance to immune checkpoint inhibitors in non-small cell lung cancer: Mechanisms, combination strategies and clinical perspectives (Review).

Jiange Mu, Qiqi Xu · Mol Clin Oncol · Oct 1, 2026 · PMID 42719683 · candidate dictionary pubmed

Experience of the implementation of a lung cancer screening program at the Hospital General de Catalunya (Barcelona, Spain).

Irene Moya-Horno, Adrián González-Marrón, Paula Barcos-Muñoz et al. · Curr Probl Cancer · Oct 1, 2026 · PMID 42617374 · candidate dictionary pubmed

Corrigendum to "EML4-ALK fusion in small cell lung cancer: clinical and molecular insights from a rare case" [Lung Cancer 202 (2025) 108497].

Ghina Jaber, Chris Raffoul, Tasnim Diab et al. · Lung Cancer · Oct 1, 2026 · PMID 42697737 · candidate dictionary pubmed

Fusion isoform multiplicity and impact on treatment outcomes in ALK-rearranged non-small cell lung cancer with next-generation tyrosine kinase inhibitors.

Damien Humbert, Adrien Buisson, Mathurine Basset et al. · Lung Cancer · Oct 1, 2026 · PMID 42691832 · candidate dictionary pubmed

Adjuvant immunotherapy in resectable non-small cell lung cancer with nodal downstaging.

Mengzhen You, Yang Pan, Cien Sun et al. · Lung Cancer · Oct 1, 2026 · PMID 42691831 · candidate dictionary pubmed

Clinical outcomes and genomic features of uncommon EGFR exon 19 deletion subtypes in osimertinib-treated non-small cell lung cancer.

Hiroto Hatano, Tatsuya Yoshida, Ryoko Inaba Higashiyama et al. · Lung Cancer · Oct 1, 2026 · PMID 42691830 · candidate dictionary pubmed

First-line pyrotinib plus apatinib in advanced non-small cell lung cancer harboring HER2 mutations or amplification: a phase II trial.

Yaning Yang, Wenxin Jiang, Guangjian Yang et al. · Lung Cancer · Oct 1, 2026 · PMID 42691829 · candidate dictionary pubmed

IL20RB drives non-small cell lung cancer progression and immune evasion via K267‑dependent activation of JAK2 phosphorylation and STAT3 signaling.

Yanghao Wang, Guoyu Li, Weizhou Wang et al. · Lung Cancer · Oct 1, 2026 · PMID 42685527 · candidate dictionary pubmed

Utility of artificial intelligence for identifying thoracic lymphadenopathy in lung cancer.

Muhiddin Dervis, Anushree Burade, Michael Lanuti et al. · Lung Cancer · Oct 1, 2026 · PMID 42673682 · candidate dictionary pubmed

Treatment patterns and outcomes in advanced and metastatic lung cancer in France: Results from the Epidemiological Strategy and medical Economics (ESME) database lung cancer in France.

Nicolas Girard, Matthieu Carton, Pauline Macouillard et al. · Lung Cancer · Oct 1, 2026 · PMID 42660015 · candidate dictionary pubmed

The impact of EGFR subtype combined with TP53 co-mutation status on survival outcomes with front-line osimertinib in non-small cell lung cancer (NSCLC).

Hye Sung Kim, Li Zhang, J Nicholas Bodor et al. · Lung Cancer · Oct 1, 2026 · PMID 42660014 · candidate dictionary pubmed

RAD001-Adjuvanted Influenza Vaccine Synergizes With Anti-Programmed Cell Death Protein 1 Therapy to Enhance Antitumor Immunity in Programmed Cell Death Ligand 1-Low Murine Lung Cancer.

Hui Lin Ou, Jia Sun, Shi Bo Wu · World J Oncol · Oct 1, 2026 · PMID 42730473 · candidate dictionary pubmed

A Mitochondrial-Related Gene Signature for Diagnosis and Immune Microenvironment Modulation in Lung Cancer and Venous Thromboembolism.

Xue Li Zhang, Ai Li Gao, Zhan Ju Liu · World J Oncol · Oct 1, 2026 · PMID 42730163 · candidate dictionary pubmed

Reprogramming PD-L1 endosomal recycling and lysosomal degradation via engineered exosome-based nanocomposites overcomes immune resistance in lung cancer brain metastasis.

Xiujuan Hong, Xiaoqi Wang, Wankun Wang et al. · Mater Today Bio · Oct 1, 2026 · PMID 42729718 · candidate dictionary pubmed

Clinical utility of circulating tumor-derived endothelial cells in lung cancer detection and prognosis prediction.

Xiang Li, Jun Yang, Bin Chen et al. · Oncol Lett · Oct 1, 2026 · PMID 42729558 · candidate dictionary pubmed